Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Micropharma (intellectual property assets)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Portfolio of intellectual property assets in the probiotic sector. The assets are related to development of the probiotic strain Lactobacillus reuteri NCIMB 30242, which is offered under the mark LRC and the Cardioviva brand of probiotics. It is protected by two families of registered patents.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Food Products
Acquirer
Primary Office
  • Montreal
  • Canada

Micropharma (intellectual property assets) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Micropharma (intellectual property assets)‘s full profile, request access.

Request full access to PitchBook

Micropharma (intellectual property assets) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Micropharma (intellectual property assets)‘s full profile, request access.

Request full access to PitchBook

Micropharma (intellectual property assets) Executive Team (1)

Name Title Board
Seat
Contact
Info
Ryan Jones Chief Executive Officer